Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

per Kee, Kwong-Ming, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan
Publicat 2014

Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival

per Kee, Kwong Ming, Wang, Jing-Houng, Wang, Chih-Chi, Cheng, Yu-Fan, Lu, Sheng-Nan
Publicat a Sci Rep (2016)

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function

per Chien, Tai-Long, Wang, Jing-Houng, Kee, Kwong-Ming, Chen, Chien-Hung, Hung, Chao-Hung, Lu, Sheng-Nan
Publicat a PLoS One (2016)

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening

per Kuo, Yuan-Hung, Kee, Kwong-Ming, Hsu, Nien-Tzu, Wang, Jing-Houng, Hsiao, Chang-Chun, Chen, Yi, Lu, Sheng-Nan
Publicat a PLoS One (2019)

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

per Yen, Yi-Hao, Kee, Kwong-Ming, Chen, Chien-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung
Publicat a PLoS One (2019)

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

per Yen, Yi-Hao, Chen, Chien-Hung, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan, Kee, Kwong-Ming, Hu, Tsung-Hui
Publicat a PLoS One (2019)

Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation

per Yeh, Wen-Shuo, Chiang, Pi-Ling, Kee, Kwong-Ming, Chang, Ching-Di, Lu, Sheng-Nan, Chen, Chien-Hung, Wang, Jing-Houng
Publicat a Medicine (Baltimore) (2020)

Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community

per Kuo, Yuan-Hung, Tsai, Ming-Chao, Kee, Kwong-Ming, Chang, Kuo-Chin, Wang, Jing-Houng, Lin, Chun-Yin, Lin, Sheng-Che, Lu, Sheng-Nan
Publicat a PLoS One (2016)

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation

per Chen, Hsin-Yeh, Lu, Sheng-Nan, Hung, Chao-Hung, Wang, Jing-Houng, Chen, Chien-Hung, Yen, Yi-Hao, Kuo, Yuan-Hung, Kee, Kwong-Ming
Publicat a PLoS One (2020)

Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case

per Wang, Ming-Hung, Kuo, Yuan-Hung, Yen, Yi-Hao, Lu, Sheng-Nan, Wang, Jing-Houng, Chen, Chien-Hung, Hung, Chao-Hung, Kee, Kwong-Ming
Publicat a Case Rep Oncol (2021)

Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis

per Kuo, Yuan-Hung, Lu, Sheng-Nan, Hung, Chao-Hung, Kee, Kwong-Ming, Chen, Chien-Hung, Hu, Tsung-Hui, Lee, Chuan-Mo, Changchien, Chi-Sin, Wang, Jing-Houng
Publicat 2010

A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort

per Yen, Yi-Hao, Kee, Kwong-Ming, Kuo, Fang-Ying, Chang, Kuo-Chin, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung
Publicat a Medicine (Baltimore) (2018)

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

per Kuo, Yuan-Hung, Yen, Yi-Hao, Chen, Yen-Yang, Kee, Kwong-Ming, Hung, Chao-Hung, Lu, Sheng-Nan, Hu, Tsung-Hui, Chen, Chien-Hung, Wang, Jing-Houng
Publicat a Front Oncol (2021)

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

per Yen, Yi-Hao, Kuo, Fang-Ying, Kee, Kwong-Ming, Chang, Kuo-Chin, Tsai, Ming-Chao, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung
Publicat a PLoS One (2018)

Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care

per Kuo, Yuan-Hung, Chen, Pao-Fei, Wang, Jing-Houng, Chang, Kuo-Chin, Kee, Kwong-Ming, Tsai, Ming-Chao, Lin, Chun-Yin, Lin, Sheng-Che, Tsai, Lin-San, Chen, Shu-Chuan, Lu, Sheng-Nan
Publicat a PLoS One (2015)

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment

per Yeh, Jen-Hao, Hung, Chao-Hung, Wang, Jing-Houng, Chen, Chien-Hung, Kee, Kwong-Ming, Kuo, Chung-Mou, Yen, Yi-Hao, Cheng, Yu-Fan, Chen, Yen-Yang, Hsu, Hsuan-Chi, Lu, Sheng-Nan
Publicat a PLoS One (2015)

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy

per Huang, Pao-Yuan, Wang, Chih-Chi, Lin, Chih-Che, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Kee, Kwong-Ming, Chen, Chien-Hung, Chen, Kuang-Den, Hu, Tsung-Hui, Tsai, Ming-Chao
Publicat a J Clin Med (2019)

Tenofovir versus Entecavir in Treatment of Chronic Hepatitis B Virus with Severe Acute Exacerbation

per Hung, Chao-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Lee, Chuan-Mo, Chen, Chih-Hung, Kee, Kwong-Ming, Wang, Jing-Houng, Tsai, Ming-Chao, Kuo, Yuan-Hung, Chang, Kuo-Chin, Chiu, Yi-Chun, Chen, Chien-Hung
Publicat a Antimicrob Agents Chemother (2015)

A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation

per Hung, Chao-Hung, Kee, Kwong-Ming, Chen, Chih-Hung, Tseng, Po-lin, Tsai, Ming-Chao, Chen, Chien-Hung, Wang, Jing-Houng, Chang, Kuo-Chin, Kuo, Yuan-Hung, Yen, Yi-Hao, Hu, Tsung-Hui, Lu, Sheng-Nan
Publicat a Clin Transl Gastroenterol (2017)

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C

per Huang, Chao-Min, Chang, Kuo-Chin, Hung, Chao-Hung, Chiu, King-Wah, Lu, Sheng-Nan, Wang, Jing-Houng, Chen, Chien-Hung, Kee, Kwong-Ming, Kuo, Yuan-Hung, Tsai, Ming-Chao, Tseng, Po-Lin, Lin, Ming-Tsung, Wu, Cheng-Kun, Hu, Tsung-Hui, Cho, Chung-Lung, Yen, Yi-Hao
Publicat a PLoS One (2017)